Editorial Board
Co-Editors-in-Chief
Ricardo Correa, MD, EdD, FACE, FACP, FACMQ
Program director of the Endocrinology, Diabetes and Metabolism Fellowship Program and the director of health equity and inclusive initiatives at the Cleveland Clinic in Cleveland, Ohio
Dr Ricardo Correa is a clinical professor of medicine, director for Diversity, Equity and Inclusion for Mentoring and Belonging at Case Western Reserve University School of Medicine and the director for Longitudinal Curriculum at the Cleveland Clinic Lerner College of Medicine. He is the program director for the Endocrinology, Diabetes and Metabolism Fellowship Program and the director of health equity and inclusive initiatives at Cleveland Clinic. He is an editor and peer reviewer of multiple journals in endocrine, research and medical education. He has more than 100 article published in peer-review journals.
Sheyu Li, MD
Clinical diabetologist (consultant); Associate Professor in the Department of Endocrinology and Metabolism, MAGIC China Center, West China Hospital, Sichuan University
Dr Sheyu Li is the core team member in MAGIC China Center, Cochrane China Center and Chinese Evidence-based Medicine Center. He is now leading a platform for Chinese trustworthy clinical practice guideline, West China Recommendation (WCR), and actively participated in the work of BMJ Rapid Recommendations in collaboration with MAGIC Evidence Ecosystem Foundation and McMaster University. He is also leading an electronic medical record (EMR)-based multicentre database of diabetes (WECODe), facilitating an EMR-based clinical decision support system (CDSS) and retrospective analyses for specific clinical questions.
Amanda Iannaccio, Managing Editor
Editorial Board Members
Associate Editors
Arnav Agarwal, MD
Assistant Professor, University of Alberta, Canada
Dr Arnav Agarwal is a general internal medicine physician and clinical epidemiologist with interests in systematic reviews, trustworthy practice guidelines and related research methods. He is an Assistant Professor at the University of Alberta.
Sudipta Ashe, PhD
Senior Postdoctoral Scientist, University of California San Francisco (UCSF)
Dr Sudipta Ashe is a Senior Postdoctoral scientist at University of California San Francisco and Visiting Scientist at the University of California, Berkeley. His research interests are in the field of pancreatic diseases, primarily focusing on type 1 and type 2 diabetes and pancreatic ductal adenocarcinoma (PDAC). His work explores the intricate mechanisms of pancreas development, beta cell physiology, immune response, and metabolism. Dr Ashe’s research leverages diverse model systems, from Drosophila to human tissues, with a particular emphasis on human stem cell differentiation into islet organoids, as well as mouse and human beta cells and PDAC organoids. His expertise also includes cutting-edge high-throughput functional genomics approaches, including CRISPR-Cas9 screens coupled with scRNAseq, to dissect gene function and identify key gene regulatory networks. Furthermore, Dr Ashe is actively developing transplant technology platforms for T1D cell therapy and organ-on-chip biomedical systems to advance our understanding of complex cell biological processes. Their expertise encompasses a broad range of pancreatic development and cancer models. He is an editor and peer reviewer of multiple journals.
Amit Dey, MD
Consultant Diabetologist, Apollo Sugar Clinics, India
Dr Amit Dey is a Consultant specializing in Diabetes, Obesity, and Metabolic disorders from Kolkata, India. His areas of expertise include Diabetes and all its related disorders, Thyroid Disorders, Metabolic Syndrome, Lipid abnormalities, and other Preventive Cardio-Metabolic Diseases. He is also trained in Geriatric Medicine. Dr Dey is an active member of the Research Society for the Study of Diabetes in India (RSSDI), the American Association of Clinical Endocrinology (AACE), the American College of Physicians (ACP), and the Society of Physician Entrepreneurs (SOPE, USA). He currently serves as an Early Career Physician (ECP) Council Member of the ACP India Chapter, Joint Secretary of the Diabetes Research Welfare Association (DRWA) in Kolkata, and Secretary of the Indian Podiatry Association (IPA), West Bengal Chapter. Over the past 8 years, he has been involved in various patient awareness and healthcare training activities in the field of Diabetology. Dr Dey has presented numerous papers and posters at national and international conferences, contributed as an author to textbook chapters, and served as a speaker at various national and international conferences. Additionally, he is actively engaged as a teacher for the National Diabetes Educator Program (NDEP) and the Enhanced Post Graduate Certificate in Diabetes (EPGCD) Course. His research interests include Obesity and metabolic Syndrome, Diabetes in the Elderly, Continuous Glucose Monitoring (CGM) in Gestational Diabetes, Artificial Intelligence in Diabetes care, and Precision Diabetes Care. Dr Dey is associated on the research front as a principal investigator and co-investigator in various real-world observational studies.
Kara Mizokami-Stout, MD
Clinical Instructor, Endocrinology, Department of Endocrinology, University of Michigan, USA
Dr Kara Mizokami-Stout is an adult endocrinologist interested in the impact of psychosocial factors on diabetes self-management in the context of advanced chronic microvascular complications as well as diabetes devices including insulin pumps, continuous glucose monitors, and artificial pancreas systems.
Leo Quinlan, PhD
Lecturer, Physiology, School of Medicine NUI Galway, Ireland
Dr Leo Quinlan has a BSc in Biochemistry and PhD in Stem Cell biology. He is a lecturer in Physiology at NUI Galway since 1999 and a funded investigator at CÚRAM centre for medical device research. His research interests focus on the interface of human physiology and medical device development, with a particular emphasis on electrophysiology and neuromodulation.
Weihao Wang, PhD
Clinical Doctor, Beijing Hospital, Peking Union Medical College
Dr Weihao Wang is a joint PhD of Peking Union Medical College and the University of Queensland. His main research focus includes Pathogenesis and intervention of diabetic angiopathy, diabetes-related diseases, endocrine and metabolic diseases in the elderly. He is also interested in combining diabetes with artificial intelligence to promote accurate diagnosis and treatment of diabetes.
Ruxing Zhao
Associate Chief Physician, Qilu Hospital of Shandong University
Dr Ruxing Zhao is an Associate Chief Physician at Qilu Hospital of Shandong University, as well as an Associate Professor at Shandong University. He also serves as the Deputy Director of the Shandong Provincial Key Laboratory of Temporal Regulation and Precision Intervention in Endocrine and Metabolic Diseases. His research focuses on the role of immune-inflammatory mechanisms in endocrine and metabolic diseases, particularly how environmental factors (such as gut microbiota, dietary patterns, and lifestyle) influence glucose and lipid metabolism through circadian rhythms and epigenetic regulation. Dr Zhao leverages molecular biology, bioinformatics, and artificial intelligence to explore the underlying mechanisms and translational targets of different metabolic phenotypes in obesity and diabetes. He has developed practical tools for assessing pancreatic function and contributed to the improvement of endocrine function tests.
Past Editorial Board Members
Suresh Rama Chandran, MBBS, MRCP, Consultant, Department of Endocrinology, Singapore General Hospital (SG)
Yu Kuei (Alex) Lin, MD, Clinical Assistant Professor, Division of Metabolism, Endocrinology and Diabetes, University of Michigan
Caroline Richardson, MD, JMIR Diabetes Editor-in-Chief, George A. and Marilyn M. Bray Professor of Family Medicine, Brown University; Chair of Family Medicine, The Warren Alpert Medical School / Care New England (USA)
Dina Hafez Griauzde, MD, Assistant Professor of General Medicine, Institute for Healthcare Policy & Innovation, University of Michigan (USA)
Anu Sharma, MBBS, Assistant Professor of Medicine, University of Utah School of Medicine (USA)
Join the Editorial Board
We are currently looking to expand our Editorial Board. To apply to be an Editorial Board Member/Associate Editor, please apply using the form linked in this article. You should hold a PhD (or similar higher degree), have a publication track record (h-index>8), and ideally have some academic editing experience. FAQ Article How to become an EB member
Guest Editors & Theme Issue Proposals
JMIR Publications welcomes guest editors to assemble a theme issue on a special subtopic. For more information, please visit How to guest edit a theme issue and How to suggest a theme issue.
This may be particularly interesting for workshop and conference organizers putting together a grant-funded event (eg, with invited experts) on a topic in scope for the journal. JMIR Publications can then be used as a dissemination vehicle. (Funding through grants or other sources is usually required and should be budgeted for in grant proposals. Letters of support are available from the JMIR Publications editor, if needed. Note that granting agencies such as NLM or CIHR usually want to see some sort of knowledge translation activities in workshop proposals, and have in the past funded the JMIR Publications APFs.)
The task of the guest editor(s) is generally
- to solicit manuscripts from colleagues concerning the selected topic,
- to select peer-reviewers for incoming manuscripts,
- to make decisions (together with the editorial board) on article revisions and acceptance, and
- to write an editorial for the theme issue
- to secure funding to sponsor the APFs for published papers (usually in the $10-20k range).
Alternatively, the conference abstracts may be published in a supplement, with or without selected full papers published later in a theme issue or in regular JMIR Publications issues. See We are organizing a conference - can we publish our proceedings / abstracts in iproceedings? regarding publishing conference abstracts.